These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 18625005

  • 1. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L, Pesce G, Gallotta A, Zampieri F, Biasiolo A, Tono N, Boscato N, Gatta A, Pontisso P, Fassina G.
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [Abstract] [Full Text] [Related]

  • 2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [Abstract] [Full Text] [Related]

  • 4. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Oct; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 5. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
    Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.
    Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M.
    Cancer; 2000 Feb 01; 88(3):544-9. PubMed ID: 10649245
    [Abstract] [Full Text] [Related]

  • 8. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 01; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan 01; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 10. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G.
    Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222
    [Abstract] [Full Text] [Related]

  • 11. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
    Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M.
    Clin Gastroenterol Hepatol; 2009 Jan 15; 7(1):104-13. PubMed ID: 18849011
    [Abstract] [Full Text] [Related]

  • 12. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K, Magario N, Yokoo T, Naraki T.
    Cancer; 1999 Feb 15; 85(4):812-8. PubMed ID: 10091758
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y, Oguro M, Yanagi M, Mita Y, Suda T, Suzuki Y, Hata K, Ichii K, Asakura H.
    Cancer; 1996 May 01; 77(9):1781-6. PubMed ID: 8646674
    [Abstract] [Full Text] [Related]

  • 14. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods.
    Nomura F, Ishijima M, Horikoshi A, Nakai T, Ohnishi K.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1380-3. PubMed ID: 8677999
    [Abstract] [Full Text] [Related]

  • 15. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
    Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS.
    Hepatology; 2003 May 01; 37(5):1114-21. PubMed ID: 12717392
    [Abstract] [Full Text] [Related]

  • 16. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
    Jiang J, Wu C, Shen Y, Xu B, Zheng X, Li X, Xu N.
    Anticancer Res; 2011 Feb 01; 31(2):687-91. PubMed ID: 21378357
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Feb 01; 50(54):2072-8. PubMed ID: 14696467
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    Nakao A, Taniguchi K, Inoue S, Harada A, Nonami T, Watanabe K, Takagi H.
    Semin Surg Oncol; 1996 Feb 01; 12(3):160-3. PubMed ID: 8727604
    [Abstract] [Full Text] [Related]

  • 19. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R, Runge M, Stieber P, Meissner E.
    Anticancer Res; 1999 Feb 01; 19(4A):2489-93. PubMed ID: 10470180
    [Abstract] [Full Text] [Related]

  • 20. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
    Ertle JM, Heider D, Wichert M, Keller B, Kueper R, Hilgard P, Gerken G, Schlaak JF.
    Digestion; 2013 Feb 01; 87(2):121-31. PubMed ID: 23406785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.